PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
HEAL.L vs. UKRE.L
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


HEAL.LUKRE.L
YTD Return6.07%-3.58%
1Y Return25.82%4.64%
3Y Return (Ann)-7.46%-6.76%
5Y Return (Ann)5.63%-2.23%
Sharpe Ratio1.890.43
Sortino Ratio2.900.75
Omega Ratio1.331.08
Calmar Ratio0.650.20
Martin Ratio8.721.49
Ulcer Index3.29%3.57%
Daily Std Dev15.31%12.53%
Max Drawdown-46.43%-31.82%
Current Drawdown-29.48%-22.19%

Correlation

-0.50.00.51.00.4

The correlation between HEAL.L and UKRE.L is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

HEAL.L vs. UKRE.L - Performance Comparison

In the year-to-date period, HEAL.L achieves a 6.07% return, which is significantly higher than UKRE.L's -3.58% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-2.00%0.00%2.00%4.00%6.00%8.00%10.00%12.00%JuneJulyAugustSeptemberOctoberNovember
7.24%
0.52%
HEAL.L
UKRE.L

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


HEAL.L vs. UKRE.L - Expense Ratio Comparison

Both HEAL.L and UKRE.L have an expense ratio of 0.40%.


HEAL.L
iShares Healthcare Innovation UCITS ETF USD (Acc)
Expense ratio chart for HEAL.L: current value at 0.40% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.40%
Expense ratio chart for UKRE.L: current value at 0.40% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.40%

Risk-Adjusted Performance

HEAL.L vs. UKRE.L - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Healthcare Innovation UCITS ETF USD (Acc) (HEAL.L) and iShares MSCI Target UK Real Estate UCITS ETF (UKRE.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


HEAL.L
Sharpe ratio
The chart of Sharpe ratio for HEAL.L, currently valued at 1.89, compared to the broader market-2.000.002.004.006.001.89
Sortino ratio
The chart of Sortino ratio for HEAL.L, currently valued at 2.90, compared to the broader market-2.000.002.004.006.008.0010.0012.002.90
Omega ratio
The chart of Omega ratio for HEAL.L, currently valued at 1.33, compared to the broader market1.001.502.002.503.001.33
Calmar ratio
The chart of Calmar ratio for HEAL.L, currently valued at 0.65, compared to the broader market0.005.0010.0015.000.65
Martin ratio
The chart of Martin ratio for HEAL.L, currently valued at 8.72, compared to the broader market0.0020.0040.0060.0080.00100.008.72
UKRE.L
Sharpe ratio
The chart of Sharpe ratio for UKRE.L, currently valued at 0.71, compared to the broader market-2.000.002.004.006.000.71
Sortino ratio
The chart of Sortino ratio for UKRE.L, currently valued at 1.23, compared to the broader market-2.000.002.004.006.008.0010.0012.001.23
Omega ratio
The chart of Omega ratio for UKRE.L, currently valued at 1.14, compared to the broader market1.001.502.002.503.001.14
Calmar ratio
The chart of Calmar ratio for UKRE.L, currently valued at 0.34, compared to the broader market0.005.0010.0015.000.34
Martin ratio
The chart of Martin ratio for UKRE.L, currently valued at 2.51, compared to the broader market0.0020.0040.0060.0080.00100.002.51

HEAL.L vs. UKRE.L - Sharpe Ratio Comparison

The current HEAL.L Sharpe Ratio is 1.89, which is higher than the UKRE.L Sharpe Ratio of 0.43. The chart below compares the historical Sharpe Ratios of HEAL.L and UKRE.L, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00JuneJulyAugustSeptemberOctoberNovember
1.89
0.71
HEAL.L
UKRE.L

Dividends

HEAL.L vs. UKRE.L - Dividend Comparison

HEAL.L has not paid dividends to shareholders, while UKRE.L's dividend yield for the trailing twelve months is around 7.42%.


TTM202320222021202020192018201720162015
HEAL.L
iShares Healthcare Innovation UCITS ETF USD (Acc)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
UKRE.L
iShares MSCI Target UK Real Estate UCITS ETF
7.42%5.22%1.90%0.86%1.45%2.09%2.60%2.32%1.76%0.86%

Drawdowns

HEAL.L vs. UKRE.L - Drawdown Comparison

The maximum HEAL.L drawdown since its inception was -46.43%, which is greater than UKRE.L's maximum drawdown of -31.82%. Use the drawdown chart below to compare losses from any high point for HEAL.L and UKRE.L. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%JuneJulyAugustSeptemberOctoberNovember
-29.48%
-25.70%
HEAL.L
UKRE.L

Volatility

HEAL.L vs. UKRE.L - Volatility Comparison

The current volatility for iShares Healthcare Innovation UCITS ETF USD (Acc) (HEAL.L) is 3.24%, while iShares MSCI Target UK Real Estate UCITS ETF (UKRE.L) has a volatility of 4.46%. This indicates that HEAL.L experiences smaller price fluctuations and is considered to be less risky than UKRE.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%JuneJulyAugustSeptemberOctoberNovember
3.24%
4.46%
HEAL.L
UKRE.L